Charles Schwab Investment Management Inc. Buys 21,766 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Charles Schwab Investment Management Inc. grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,002,283 shares of the company’s stock after purchasing an additional 21,766 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.17% of HealthEquity worth $66,451,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Advisor Partners II LLC bought a new stake in HealthEquity during the 3rd quarter valued at approximately $206,000. Fifth Third Bancorp boosted its position in shares of HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after purchasing an additional 161 shares in the last quarter. Orion Portfolio Solutions LLC grew its stake in HealthEquity by 38.8% in the third quarter. Orion Portfolio Solutions LLC now owns 4,590 shares of the company’s stock worth $335,000 after purchasing an additional 1,284 shares during the period. Principal Financial Group Inc. grew its stake in HealthEquity by 0.4% in the third quarter. Principal Financial Group Inc. now owns 340,740 shares of the company’s stock worth $24,891,000 after purchasing an additional 1,434 shares during the period. Finally, Lisanti Capital Growth LLC bought a new position in HealthEquity in the third quarter worth $13,221,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. JMP Securities began coverage on shares of HealthEquity in a research report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 target price on the stock. KeyCorp upped their price objective on shares of HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, March 22nd. JPMorgan Chase & Co. raised their target price on shares of HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research note on Tuesday, April 2nd. Barclays boosted their price target on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research report on Friday, February 23rd. Finally, Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of HealthEquity in a research report on Friday, March 22nd. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

HealthEquity Stock Down 1.3 %

HealthEquity stock opened at $75.85 on Thursday. HealthEquity, Inc. has a 12 month low of $54.09 and a 12 month high of $84.49. The stock has a fifty day simple moving average of $80.11 and a two-hundred day simple moving average of $74.93. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. The firm has a market cap of $6.51 billion, a price-to-earnings ratio of 118.52, a PEG ratio of 1.26 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. The business had revenue of $262.39 million during the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. Equities analysts predict that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $82.59, for a total transaction of $211,265.22. Following the transaction, the executive vice president now directly owns 47,438 shares of the company’s stock, valued at approximately $3,917,904.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $82.59, for a total transaction of $211,265.22. Following the completion of the sale, the executive vice president now owns 47,438 shares of the company’s stock, valued at $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 68,823 shares of company stock worth $5,482,975. 2.70% of the stock is owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.